stemmacolore
Cerca

Genomic Copy Number Variation and TERT promoter mutation analyses as tools to predict the response to targeted therapy in BRAFmutated metastatic melanoma patients

Genomic Copy Number Variation and TERT promoter mutation analyses as tools to predict the response to targeted therapy in BRAFmutated metastatic melanoma patients

Stato

aperto

Copertura

Nazionale

Tipologia

Ricerca di base/clinica

Ruolo di capofila/partner

Capofila

Ente finanziatore

IOV - IRCCS

Principal Investigator

Dott.ssa Chiara Menin

Anno di finanziamento

2018
Torna in alto